Opendata, web and dolomites

OMiProbe

Bio-optical probe technology for safe, fast and non-destructive cancer diagnosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "OMiProbe" data sheet

The following table provides information about the project.

Coordinator
INPHOTECH SP ZOO 

Organization address
address: UL. POZNAŃSKA 400
city: OŁTARZEW
postcode: 05-850
website: www.inphotech.eu

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Project website http://inphotech.pl/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-03-01   to  2016-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INPHOTECH SP ZOO PL (OŁTARZEW) coordinator 50˙000.00

Map

 Project objective

Our novel OMiProbe (Optical Fibre Micro Probe) is an optical device that allows quantitative cellular processes studies, even inside a single cell, and carries the disruptive potential for real-time, ‘in-vivo’ cancer diagnosis. At the current stage of development, with a diameter of less than 6 µm and a biologically active (antibodies) coating applied at the tip of the fibre optic probe, we are able to perform cellular level spectral identification of certain types of carcinomas, specifically breast cancer. (Carcinomas type of cancer comprise 80% to 90% of all cancers)

The state of the art methods of cancer diagnosis require cutting/extracting tissue sample in a process called a biopsy, and consequently make non-destructive and live observations impossible. We believe OMiProbe technology offers an alternative to the destructive process of biopsy, and presents a safe, minimally invasive method for instantaneous cancer diagnosis and identification. With the OMiProbe, tissue may be examined ‘in vivo’ by insertion of the needle-sized OMiProbe into the suspected tissue, on live patients during standard medical examination, or during surgery.

For better understanding and curing of cancer, early detection and diagnosis play a critical role. Cancer is in many cases treatable, and early detection increases the chance of cure substantially. However, it is not sufficient to define if the patient is ill or not. A more careful and prompt identification and examination of ill cells of the patient are needed to determine optimal treatment and approach. Today, such studies are difficult to quantify and impossible to realize non-destructively and in real-time. However, InPhoTech’s OMiProbe may allow to do just that.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OMIPROBE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OMIPROBE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Meshporto_smeIns1_2 (2018)

PsstMenu allows customers to place orders directly from home or restaurant tables using only a smartphone.

Read More  

Assist (2015)

Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone

Read More  

AIM (2018)

Augmented Reality Assisted System for Utilities Infrastructure Management

Read More